文献速递妇科

美国根治性肿瘤细胞减灭术的趋势及相关因素:集中化诊疗的依据

Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.
PubMed 文献 · Gynecol Oncol · 2017-03-30

分析美国全国住院患者样本库1993至2011年晚期卵巢癌肿瘤细胞减灭术住院记录,比较简单盆腔、广泛盆腔和广泛上腹部手术的年趋势。2007至2011年间广泛盆腔和广泛上腹部切除率上升,高手术量卵巢癌中心更常实施广泛上腹部手术且并发症更少,作者支持进一步研究集中化卵巢癌诊疗模式。

要点

  • 广泛盆腔切除率从8%升至18.1%,广泛上腹部切除率从1.3%升至5.4%(P<0.01)。
  • 高手术量卵巢癌中心更常实施广泛上腹部手术(OR 2.65)。
  • 高手术量医院广泛上腹部手术后并发症率10.2%,低于低、中手术量医院的21.2%和21.7%(P=0.01)。

核心结论

  • 美国晚期卵巢癌根治性肿瘤细胞减灭术的实施率正在上升。
  • 在高手术量医院,患者接受更根治的手术且并发症更少,支持进一步研究集中化卵巢癌诊疗模式。

研究设计与样本

  • 基于美国全国住院患者样本库的分析,纳入1993至2011年所有晚期卵巢癌肿瘤细胞减灭术住院记录,共分析28,677例未加权住院。
  • 手术分为简单盆腔、广泛盆腔和广泛上腹部手术三类,分析肿瘤细胞减灭术的年趋势。
  • 在2007至2011年间探讨患者因素和医院因素与手术根治性及围手术期并发症的关联。

主要发现

  • 广泛盆腔切除率从8%升至18.1%,广泛上腹部切除率从1.3%升至5.4%(P<0.01)。
  • 多因素分析显示,东北部(OR 1.44)或西海岸(OR 1.47)、城市医院(OR 2.3)、大型医院(OR 1.4)或拥有私人保险(OR 1.45)的患者更可能接受广泛上腹部切除。
  • 高手术量卵巢癌中心更常实施广泛上腹部手术(OR 2.65)。
  • 高手术量医院广泛上腹部手术后并发症率为10.2%,低手术量医院为21.2%,中手术量医院为21.7%(P=0.01)。
  • 高手术量医院患者出血、血管/神经损伤、住院时间延长和非常规出院的发生率低于较低手术量医院(P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the US national trends and factors associated with cytoreductive surgical radicality in women with advanced ovarian cancer (OC). METHODS: An analysis of the National Inpatient Sample database was performed. All admissions from 1993 to 2011 for advanced OC cytoreductive surgery (CRS) were identified and categorized as simple pelvic (SP), extensive pelvic (EP), and extensive upper abdominal (EUA) surgery. Annual trends in CRS were analyzed. Associations between patient- and hospital-specific factors, with CRS radicality as well as perioperative complications were explored between 2007 and 2011. RESULTS: In total, 28,677 un-weighted admissions were analyzed. The rate of EP and EUA resections increased over time (8% to 18.1% and 1.3% to 5.4%, P<0.01, respectively). On multivariate analysis, patients were more likely to undergo EUA resections in the Northeast (OR 1.44) or West Coast (OR 1.47) at urban (OR 2.3), or large hospitals (OR 1.4), or if they had private insurance (OR 1.45). EUA surgeries were performed more frequently at high-volume ovarian cancer centers (OR 2.65); additionally, fewer complications were observed after EUA at high compared with low and medium volume hospitals (10.2%, 21.2%, and 21.7%, respectively; P=0.01). Specifically, patients treated at high volume hospitals experienced lower rates of hemorrhage, vascular/nerve injury, prolonged hospitalization, and non-routine discharge than at lower (P<0.05). CONCLUSIONS: The US rate of radical cytoreductive surgery for advanced ovarian cancer is increasing. At high-volume hospitals, patients receive more radical surgery with fewer complications, supporting further study of a centralized ovarian cancer care model.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Sinno AK, Li X, Thompson RE, et al. Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care. Gynecol Oncol. 2017. PMID: 28366546. doi:10.1016/j.ygyno.2017.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。